ICGC Project on Early Onset Prostate Cancer

Prostate cancer is the most frequent malignant tumor in males and the second most frequent cause of cancer-related death. Currently, in Germany, more than 60,000 prostate cancers are diagnosed every year. Although most of these patients are treated in a curative attempt, more than 10,000 German men die from prostate cancer annually. Owing to the demographic changes of our society, a further doubling of prostate cancer incidences during the next 20 years is expected.

In cooperation with partners from the University Medical Center Hamburg-Eppendorf (UKE), Max Planck Institute for Molecular Genetics (MPI-MG), European Molecular Biology Laboratory (EMBL), National Center for Tumor Diseases Heidelberg (NCT) and several groups from the German Cancer Researhc Center (DKFZ) we will analyze the genome and epigenome of early onset prostate cancer (i.e. diagnosis below the age of 50).

Further information

• ICGC Early Onset Prostate Cancer (Germany)